4
Changes in Ownership
Edesa Biotech, Inc. Filed Acc 0001171843-25-000868
Options or other derivatives
- Chief Executive Officer acquired 100 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Nijhawan Pardeep · Chief Executive Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-02-12 | Grant or award : show line 1 in the form Series B-1 Convertible Preferred Shares | +100 | 100 | D |
Loading xslF345X05/ownership.xml…